research and development enterprise had been built on a foundation of hidden assumptions and unsubstantiated claims.
That foundation is beginning to collapse. In 2006, NASA launched its commercial cargo and crew initiative, which funds the private sector to "develop and demonstrate safe, reliable, and cost-effective space transportation capabilities". The programme thus concedes that NASA cannot mount new missions at affordable costs or within reasonable time-frames. Indeed, in January the agency announced that the $16 billion and six years allocated by Congress for it to build a new heavy-lift vehicle was insufficient, yet a month earlier, SpaceX Corporation in Hawthorne, California, had completed the first orbit and recovery of a commercial spacecraft, for a total cost of less than $1 billion. In 2007, Congress, having lost confidence in the DOE, decided that the country needed a new organization to catalyse innovation in energy technology. The result is the Advanced Research Projects Agency-Energy (ARPA-E), which is designed to "bring a freshness, excitement, and sense of mission to energy research" -virtues apparently absent from the existing department. ARPA-E's focus is on highrisk R&D and collaborations between universities and private firms to move promising technologies into the marketplace (see page 145). Even the NIH, flagship of the nation's healthresearch system, is now showing signs of self-doubt. The agency receives half of all US government money spent on civilian research, and owes its powerful political and scientific reputation to the widespread belief that spending billions on cutting-edge basic biomedical science is the best route to better health. Yet public-health indicators in the United States continue to lag behind those in many other nations. The NIH's leaders hope to turn this around with a new National Center for Advancing Translational Science (see page 135).
These changes signal an uncoordinated but government-wide reaction to an inescapable reality. The civilian research agencies were designed as temples of scientific excellence and technological prowess, but they lack the institutional architecture of the cold-war militaryindustrial complex, and are ill-structured to create and sustain essential links between knowledge generation, technological innovation and desired social outcomes. It is not a matter of basic versus applied research, but of insular versus integrated approaches. If this is truly our generation's Sputnik moment, it will take more than money. The United States must transform its science enterprise to enhance links between research and its application to national needs. 
